Zobrazeno 1 - 10
of 10
pro vyhledávání: '"V. Faura"'
Autor:
Manglio Rizzo, F. Rizzi, A. Perfetti, G. Recondo, V. Faura, J.N. Minatta, L. Lupinacci, M. Cerini, A. Kuzminin, V. Peuchot, M. Naveira, V. Bluthgen
Publikováno v:
Journal of Thoracic Oncology. 16:S240-S241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2f30e818a8cf95e285941a00e142b17
https://doi.org/10.1016/j.jtho.2021.01.335
https://doi.org/10.1016/j.jtho.2021.01.335
Autor:
Nuria Viñolas, M. Fontanillas, García-Conde J, Alcalá A, Llorente A, L. Hernandez-Nieto, Jordi Estapé, J. Maldonado, Armando López-Guillermo, A. Zubizarreta, J. Bladé, M. V. Faura, Emili Montserrat
Publikováno v:
European Journal of Haematology. 57:377-383
From May 1985 to May 1989, 175 patients with previously untreated aggressive non-Hodgkin's lymphoma were randomized to receive CHOP or ProMACE-CytaBOM. Eligibility criteria included follicular large-cell, diffuse small cleaved-cell, diffuse mixed, di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67b1a79aa49a3bee3474eab1dc02067c
https://doi.org/10.1111/j.1600-0609.1996.tb01396.x
https://doi.org/10.1111/j.1600-0609.1996.tb01396.x
Autor:
E, Montserrat, J, García-Conde, N, Viñolas, A, López-Guillermo, L, Hernández-Nieto, A, Zubizarreta, J, Maldonado, A, Alcalá, M V, Faura, A, Llorente, J, Bladé, M, Fontanillas, J, Estapé
Publikováno v:
European journal of haematology. 57(5)
From May 1985 to May 1989, 175 patients with previously untreated aggressive non-Hodgkin's lymphoma were randomized to receive CHOP or ProMACE-CytaBOM. Eligibility criteria included follicular large-cell diffuse small cleaved-cell, diffuse mixed, dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4fbf27a058f283e2575a240f6ac75447
https://pubmed.ncbi.nlm.nih.gov/9003479
https://pubmed.ncbi.nlm.nih.gov/9003479
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jesús E. Maldonado, R. Jimenez Galindo, Marissa Daniels, Moro Mj, J. Bladé, Carmen Alonso, Juan Sanchis, Jordi Estapé, Carles Besses, Albert Domingo, J. Fernández Calvo, J. Tortosa, Rozman C, M. V. Faura, J. M. Hernández Martín, Javier García-Conde, Francisco Ortega, A Alcalá, Juan Besalduch, L. Hernandez Nieto, J F San Miguel, Mayans J, Daniel Rubio, A. Zubizarreta, M. A. Sanz Sanz
Publikováno v:
Blut. 60(6)
Between January 1985 and December 1988, 386 patients with multiple myeloma were randomized to receive either MP or combination chemotherapy based on alternating cycles of VCMP and VBAP. The major prognostic parameters did not differ significantly bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::220a60b0325cbde2f8a0eaceac92c4b5
https://pubmed.ncbi.nlm.nih.gov/2198075
https://pubmed.ncbi.nlm.nih.gov/2198075
Publikováno v:
Sangre. 21(3B)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aeafcc725fc11f25196c0750823a222c
https://pubmed.ncbi.nlm.nih.gov/982240
https://pubmed.ncbi.nlm.nih.gov/982240
Publikováno v:
Sangre. 22(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d488c9c89973b45f76bb29c4060da30a
https://pubmed.ncbi.nlm.nih.gov/264707
https://pubmed.ncbi.nlm.nih.gov/264707
Publikováno v:
Sangre. 24(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df5bc4d072ea5352291c53c719b7fd98
https://pubmed.ncbi.nlm.nih.gov/538546
https://pubmed.ncbi.nlm.nih.gov/538546
Autor:
D, Rubio Felix, M P, Giraldo, A, Raichs, J C, García Zueco, P, Mur, M V, Faura, E, Ruíz-Marcuello, M A, Piñan
Publikováno v:
Sangre. 25(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5463b2471f790a337ea42402a3733755
https://pubmed.ncbi.nlm.nih.gov/7384962
https://pubmed.ncbi.nlm.nih.gov/7384962
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.